Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bayona J, et al.
2012-08-28 • PLOS Medicine
2012-08-28 • PLOS Medicine
Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the ...
2012-12-04 • International Journal of Tuberculosis and Lung Disease
2012-12-04 • International Journal of Tuberculosis and Lung Disease
BACKGROUND: Scaling up treatment for multidrug-resistant tuberculosis is a global health priority. However, current treatment regimens are long and associated with side effects, and defa...